Brief Research Report
Published on 22 Oct 2020
Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation
in Hematology
Frontiers in Medicine
doi 10.3389/fmed.2020.585628
- 7,884 views
- 12 citations
